Drug - Raptiva

Raptiva is medicine given by injection and is used to treat adult patients (18 years or older) with moderate to severe plaque psoriasis. Psoriasis is a chronic, non-contagious autoimmune disease which affects the skin and joints. It commonly causes red scaly patches to appear on the skin. Raptiva is approved by the U.S. Food and Drug Administration (FDA) in October 2003 for the treatment of moderate-to-severe psoriasis.

Recently, FDA announced that it was investigating recent reports of Raptiva causing three deaths from Progressive multifocal leukoencephalopathy or PML. PML is a rare and usually fatal viral disease of the brain. It occurs almost exclusively in people with severe immune deficiency, for example transplant patients on immunosuppressive medications, or AIDS patients. Besides, Raptiva has also been associated with meningitis, immune-mediated hemolytic anemia, and other life-threatening infections.

If you or your loved one is currently taking this drug for the psoriasis treatment, you might want to find out more information related to Raptiva, Raptiva PML and Raptiva side effects. Two recommended websites for you to visit are:http://www.youhaverights.com/dangerous-drugs/raptiva and also http://www.raptivapml.com/.

It is warned that you should consult your healthcare provider before start using Raptiva